SURGICAL APPROACH TO L-DOPA-INDUCED DYSKINESIAS

被引:17
|
作者
Sankar, Tejas [1 ]
Lozano, Andres M. [1 ]
机构
[1] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada
关键词
DEEP-BRAIN-STIMULATION; LEVODOPA-INDUCED DYSKINESIAS; LEKSELLS POSTEROVENTRAL PALLIDOTOMY; SUBTHALAMIC NUCLEUS STIMULATION; ADVANCED PARKINSONS-DISEASE; 2-YEAR FOLLOW-UP; GLOBUS-PALLIDUS; BASAL GANGLIA; UNILATERAL PALLIDOTOMY; BILATERAL STIMULATION;
D O I
10.1016/B978-0-12-381328-2.00006-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Many patients treated chronically with L-dopa for Parkinson disease (PD) become functionally disabled by L-dopa-induced dyskinesias (LID). Evolved from early empirical procedures, modern stereotactic surgical lesioning techniques and deep brain stimulation (DBS) can effectively treat LID while simultaneously improving the cardinal motor symptoms of PD. Here we review the common surgical targets used to treat LID, and compare their relative efficacy. We explain the anti-dyskinetic action of surgery at each of these targets based on evolving models of basal ganglia function. Finally, we discuss the appropriate selection of patients with LID for surgery and address relevant technical and management issues in these patients.
引用
收藏
页码:151 / 171
页数:21
相关论文
共 50 条
  • [1] Pathophysiology of L-dopa-induced dyskinesias
    Bédard, PJ
    Blanchet, PJ
    Lévesque, D
    Soghomonian, JJ
    Grondin, R
    Morissette, M
    Goulet, M
    Calon, F
    Falardeau, P
    Gomez-Mancilla, B
    Doucet, JP
    Robertson, GS
    DiPaolo, T
    [J]. MOVEMENT DISORDERS, 1999, 14 : 4 - 8
  • [2] Mirtazapine in L-dopa-induced dyskinesias
    Meco, G
    Fabrizio, E
    Di Rezze, S
    Alessandri, A
    Pratesi, L
    [J]. CLINICAL NEUROPHARMACOLOGY, 2003, 26 (04) : 179 - 181
  • [3] Mirtazapine in L-dopa-induced dyskinesias
    Fabrizio, E
    Vanacore, N
    Pratesi, L
    Di Rezze, S
    Alessandri, A
    Meco, G
    [J]. MOVEMENT DISORDERS, 2002, 17 : S107 - S107
  • [4] A unified dyskinesias rating scale for L-dopa-induced dyskinesias?
    Nutt, J
    [J]. MOVEMENT DISORDERS, 1999, 14 : 74 - 74
  • [5] Medical treatment of L-dopa-induced dyskinesias
    Rascol, O
    Brefel-Courbon, C
    Payoux, P
    Ferreira, JF
    [J]. MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE, 2002, 51 : 409 - 415
  • [6] Identifying the transcriptomic signature of L-DOPA-induced dyskinesias
    Smith, L. M.
    Duncan, E. J.
    Parr-Brownlie, L. C.
    Black, M. A.
    Dearden, P. K.
    Reynolds, J. N. J.
    [J]. MOVEMENT DISORDERS, 2013, 28 : S211 - S211
  • [7] The striatal cholinergic system in L-dopa-induced dyskinesias
    Perez, X. A.
    Bordia, T.
    Quik, M.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (08) : 1251 - 1262
  • [8] The striatal cholinergic system in l-dopa-induced dyskinesias
    X. A. Perez
    T. Bordia
    M. Quik
    [J]. Journal of Neural Transmission, 2018, 125 : 1251 - 1262
  • [9] DEANOL AND PHYSOSTIGMINE IN TREATMENT OF L-DOPA-INDUCED DYSKINESIAS
    LINDEBOOM, SF
    LAKKE, JPWF
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1978, 58 (02): : 134 - 138
  • [10] Mechanisms and treatment of L-DOPA-induced dyskinesias - Introduction
    Danysz, W
    [J]. AMINO ACIDS, 2002, 23 (1-3) : 103 - 103